Planta Med 2008; 74 - SL6
DOI: 10.1055/s-0028-1083886

S111- a post absorption/metabolism TCM drug, its anti-depression effect and a transcriptomic study

W Jia 1, 2, C Xu 1, A Zhao 1, C Yu 1, Z Yang 1
  • 1Shanghai Innovative Research Centre for Traditional Chinese Medicine (SIRC-TCM), Shanghai, China
  • 2University of British Columbia, Vancouver, Canada

Many chemical ingredients of TCM drugs are poorly absorbed and therefore do not represent the pharmacological mechanisms of the drug. We proposed that one of better approaches to modernize TCM is to study compounds post absorption and metabolism. Compounds found in the blood or target organs after taking TCM drug can be re-synthesized and combined to form a class of novel drugs namely Post Absorption/Metabolism Drugs (PAMDs). Ginseng has been used as a major ingredient in TCM for treatment of depression for many years in China. In the present study, we tested anti-depression effect of a semi-synthesized aglycone ginsenoside S111 that represents one of the post metabolism compounds of ginseng in a series of depression models. Transcriptomics of various brain regions were analysed and compared with that of untreated and fluoxetine, treated animals. Our results showed that orally given S111 daily for consecutive 10 days significantly antagonized Reserpine induced various locomotor inhibition in mice. Animals with given S111 daily, demonstrated substantial improvement in an open-field test. Furthermore, S111 inhibited 5-HT and NE uptake in the brain in acute tests. However, unlike fluoxetine, S111 does not alter concentrations of those neurotransmitters in the brain, suggesting its anti-depressant effect may be mediated by a different mechanism. Further study showed two gene expression profiles between S111 and fluoxetine, indicating that the two drugs may have quite different anti-depression mechanisms. S111 caused much less disturbance in the normal animals than that of fluoxetine and S111 had a better therapeutic efficiency. However, some genes were commonly regulated by both S111 and fluoxetine, suggesting that those genes may represent a group of targets that are critical for anti-depression. Our results are the first to show that a metabolic product of ginseng can be extremely active and perform better therapeutic functions of ginseng. We also demonstrated that approach of system biology can be used to analyze the complicated biological effects of TCM drugs.